Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
In clinical trials, treatment proved more effective than other therapies evaluated
Subscribe To Our Newsletter & Stay Updated
